NYSE:HQL abrdn Life Sciences Investors (HQL) Stock Price, News & Analysis $18.06 -0.28 (-1.53%) As of 11:28 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsDividendInsider TradesNews and TrendsOwnershipSEC FilingsShort Interest About abrdn Life Sciences Investors Stock (NYSE:HQL) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get HQL alerts:Sign Up Key Stats Today's Range$17.88▼$18.4950-Day Range$16.74▼$20.7052-Week Range$15.66▼$22.67Volume45,375 shsAverage Volume127,189 shsMarket Capitalization$549.17 millionP/E RatioN/ADividend Yield12.40%Price TargetN/AConsensus RatingN/A Company Overview abrdn Life Sciences Investors is a non-diversified, closed-end investment fund focused on companies in the life sciences and health care sectors. Rather than developing or selling products itself, the fund invests in businesses involved in areas such as biotechnology, pharmaceuticals, medical devices and related services. The fund seeks long-term capital appreciation through a portfolio that can include both publicly traded and privately held companies. Its investments may span U.S. and international markets. Previously known as Tekla Life Sciences Investors, the fund adopted its current name after abrdn became its investment adviser. Its portfolio is managed by abrdn, an asset management firm.AI Generated. May Contain Errors. Read More Receive HQL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for abrdn Life Sciences Investors and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HQL Stock News Headlinesabrdn Life Sciences Investors declares $1.50 dividendNovember 11 at 9:51 AM | seekingalpha.comabrdn Life Sciences Investors (NYSE:HQL) Share Price Breaks Above 200-Day Moving Average - What's Next?November 10 at 3:41 AM | americanbankingnews.comA little-known law has been quietly applied to your savings for years.Fox News reported that under current law, legal title to most stocks and bonds sits with a central institution, Cede and Company, not the individual investor. If a brokerage collapses and customer securities were pledged as collateral, secured creditors can legally come before account holders. Physical gold held in a self-directed IRA is registered directly to you, with no clearinghouse or central institution holding its title.November 13 at 1:00 AM | Monetary Gold (Ad)Analysis Of Abrdn Healthcare Investors (HQL): The Fund Is Currently OvervaluedNovember 2, 2026 | seekingalpha.comabrdn Life Sciences Investors (NYSE:HQL) Stock Short Interest Report for OctoberNovember 2, 2026 | americanbankingnews.comHQL: The Rally That Makes Growth Harder (Rating Downgrade)September 15, 2026 | seekingalpha.comabrdn Life Sciences Investors Q2 2026 CommentaryAugust 13, 2026 | seekingalpha.comabrdn Life Sciences Investors Q1 2026 CommentaryMay 20, 2026 | seekingalpha.comSee More Headlines HQL Stock Analysis - Frequently Asked Questions How have HQL shares performed this year? abrdn Life Sciences Investors' stock was trading at $16.79 at the start of the year. Since then, HQL stock has increased by 9.1% and is now trading at $18.3230. Who are abrdn Life Sciences Investors' major shareholders? Top institutional investors of abrdn Life Sciences Investors include Flagship Harbor Advisors LLC (1.37%), Allspring Global Investments Holdings LLC (1.37%), Advisors Asset Management Inc. (0.69%) and Formidable Asset Management LLC (0.55%). Insiders that own company stock include Saba Capital Management, LP, Kathleen Goetz, Todd Reit and Rose Dimartino. View institutional ownership trends. How do I buy shares of abrdn Life Sciences Investors? Shares of HQL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of abrdn Life Sciences Investors own? Based on aggregate information from My MarketBeat watchlists, some other companies that abrdn Life Sciences Investors investors own include abrdn Healthcare Investors (HQH), Enterprise Products Partners (EPD), AT&T (T), NVIDIA (NVDA), Western Asset Emerging Markets Debt Fund (EMD), Ares Capital (ARCC) and Reaves Utility Income Fund (UTG). Company Calendar Record date for 9/30 Dividend8/24/2026Ex-Dividend for 9/30 Dividend8/24/2026Dividend Payable9/30/2026Today11/13/2026Record date for 11/30 Dividend11/20/2026Ex-Dividend for 11/30 Dividend11/20/2026Dividend Payable11/30/2026Fiscal Year End9/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 HQL's financial health is in the Red zone, according to TradeSmith. HQL has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNYSE SectorFinance Industry Capital Markets Sub-IndustryN/A Current SymbolNYSE:HQL CIK884121 Webwww.abrdnhql.com Phone(617) 772-8500Fax617-772-8577EmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares30,410,000Free Float27,349,000Market Cap$549.17 million OptionableNot Optionable Beta0.79 The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NYSE:HQL) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredTrump compared today's market to 1929President Trump warned of a 1929-style depression if Democrats won control of Congress. On November 3, they di...USA Capital Gold | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding abrdn Life Sciences Investors Please log in to your account or sign up in order to add this asset to your watchlist. Share abrdn Life Sciences Investors With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
